Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment

Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy

Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359

Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity

Polazzi, E., Mengoni, I., Caprini, M., Peña‐Altamira, E., Kurtys, E., & Monti, B. (2012) · Neurosignals · doi:10.1159/000337115 · Cited by 9,023

Glutamate neurotoxicity and diseases of the nervous system

Choi, D. W. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 8,188

Biological insights from 108 schizophrenia-associated genetic loci

Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) · Nature · doi:10.1038/nature13595 · Cited by 7,577

From inflammation to sickness and depression: when the immune system subjugates the brain

Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395

Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour

Cryan, J. F., & Dinan, T. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3346 · Cited by 4,572

C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus

Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433

Immunobiology: the immune system in health and disease

(1995) · Choice Reviews Online · doi:10.5860/choice.32-3876 · Cited by 4,111

Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve

Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102999108 · Cited by 3,888

Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression

Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848

Executive Summary: Research Gaps at the Intersection of Pediatric Neurodevelopment, Nutrition, and Inflammation in Low-Resource Settings

Kutlesic, V., Isaacs, M. B., Freund, L. S., Hazra, R., & Raiten, D. J. (2017) · PEDIATRICS · doi:10.1542/peds.2016-2828c · Cited by 22

The preclinical discovery and development of cariprazine for the treatment of schizophrenia

Wesołowska, A., Partyka, A., Jastrzębska‐Więsek, M., & Kołaczkowski, M. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1471057 · Cited by 22

Clinical Trials and Therapeutic Rationale for Drug Repurposing in Schizophrenia

Lago, S. G., & Bahn, S. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00205 · Cited by 23

NLRP3 inflammasome mediates astroglial dysregulation of innate and adaptive immune responses in schizophrenia

Szabó, A., Akkouh, I. A., Osete, J. R., de Assis, D. R., Kondratskaya, E., Hughes, T., Ueland, T., Andreassen, O. A., & Djurovic, S. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.11.030 · Cited by 24

The Predictive Value of Endothelial Inflammatory Markers in the Onset of Schizophrenia

Radu, G., Luca, C. T., Petrescu, L., Arnăutu, D.-A., Tomescu, M., Andor, M., Citu, I. M., Mavrea, A., Buda, V. O., Tomescu, C., et al. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s240349 · Cited by 21

Repeated allergic asthma in early versus late pregnancy differentially impacts offspring brain and behavior development

Church, J. S., Tamayo, J. M., Ashwood, P., & Schwartzer, J. J. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.12.014 · Cited by 22

Associations of decreased serum total protein, albumin, and globulin with depressive severity of schizophrenia

Yin, X. Y., Cai, Y., Zhu, Z. H., Zhai, C., Li, J., Ji, C., Chen, P., Wang, J., Wu, Y. M., Chan, R. C. K., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.957671 · Cited by 21

Subchronic olanzapine exposure leads to increased expression of myelination-related genes in rat fronto-medial cortex

Ersland, K. M., Skrede, S., Stansberg, C. T., & Steen, V. M. (2017) · Translational Psychiatry · doi:10.1038/s41398-017-0008-3 · Cited by 21

Serum Levels of High Sensitivity C-reactive Protein in Drug-naïve First-episode Psychosis and Acute Exacerbation of Schizophrenia

Bolu, A., Aydın, M. S., Akgün, A., Coşkun, A., Garip, B., Öznur, T., Çelik, C., & Uzun, Ö. (2019) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2019.17.2.244 · Cited by 21

The Role of Astrocytes in the Molecular Pathophysiology of Schizophrenia: Between Neurodevelopment and Neurodegeneration

Vellucci, L., Mazza, B., Barone, A., Nasti, A., Simone, G. D., Iasevoli, F., & de Bartolomeis, A. (2025) · Biomolecules · doi:10.3390/biom15050615 · Cited by 23

Social cognition in the course of psychosis and its correlation with biomarkers in a male cohort

Ntouros, E., Karanikas, E., Floros, G., Andreou, C., Tsoura, A., Garyfallos, G., & Bozikas, V. (2018) · Cognitive Neuropsychiatry · doi:10.1080/13546805.2018.1440201 · Cited by 18

Cannabis use and human retina: The path for the study of brain synaptic transmission dysfunctions in cannabis users

Schwitzer, T., Schwan, R., Angioï-Duprez, K., Lalanne, L., Giersch, A., & Laprévote, V. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.12.001 · Cited by 20

Physical activity as an intervention in severe mental illness

Kandola, A. A., & Osborn, D. (2021) · BJPsych Advances · doi:10.1192/bja.2021.33 · Cited by 22

The relationship between TLR4/NF-κB/IL-1β signaling, cognitive impairment, and white-matter integrity in patients with stable chronic schizophrenia

Li, H., Chen, W., Gou, M., Li, W., Tong, J., Zhou, Y., Xie, T., Yu, T. Y., Feng, W., Li, Y., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.966657 · Cited by 21

Stress, Environment and Early Psychosis

Xenaki, L., Dimitrakopoulos, S., Selaković, M., & Stefanis, N. C. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230817153631 · Cited by 23

The Role of microRNA Expression in Cortical Development During Conversion to Psychosis

Zheutlin, A. B., Jeffries, C. D., Perkins, D. O., Chung, Y., Chekroud, A. M., Addington, J., Bearden, C. E., Cadenhead, K. S., Cornblatt, B. A., Mathalon, D. H., et al. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.34 · Cited by 20

Glucocorticoids and the risk of schizophrenia spectrum disorder in childhood and adolescence – A Danish nationwide study

Broberg, B. V., Sommer, I. E., Benros, M. E., Glenthoj, B. Y., Gasse, C., & Köhler‐Forsberg, O. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.03.007 · Cited by 20

Autoantibodies and Psychosis

Kelleher, E., Barry, H., Cotter, D., Corvin, A. P., & Murphy, K. C. (2019) · Current topics in behavioral neurosciences · doi:10.1007/7854_2019_90 · Cited by 20

Enhanced mitochondrial autophagy (mitophagy) in oligodendrocytes might play a role in white matter pathology in schizophrenia

Bernstein, H., Keilhoff, G., Dobrowolny, H., & Steiner, J. H. (2019) · Medical Hypotheses · doi:10.1016/j.mehy.2019.109443 · Cited by 20

Early Celastrol Administration Prevents Ketamine-Induced Psychotic-Like Behavioral Dysfunctions, Oxidative Stress and IL-10 Reduction in The Cerebellum of Adult Mice

Schiavone, S., Tucci, P., Trabace, L., & Morgese, M. G. (2019) · Molecules · doi:10.3390/molecules24213993 · Cited by 20

Crocus sativus L. Extracts and Its Constituents Crocins and Safranal; Potential Candidates for Schizophrenia Treatment?

Pitsikas, N. (2021) · Molecules · doi:10.3390/molecules26051237 · Cited by 20

Toxocara infection/exposure and the risk of schizophrenia: a systematic review and meta-analysis.

Taghipour, A., Habibpour, H., Mirzapour, A., & Rostami, A. (2021) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1093/trstmh/trab056 · Cited by 20

Transcriptional profile of pyramidal neurons in chronic schizophrenia reveals lamina-specific dysfunction of neuronal immunity

Wu, X., Shukla, R., Alganem, K., Zhang, X., Eby, H., Devine, E. A., DePasquale, E. A. K., Reigle, J. K., Simmons, M. S., Hahn, M., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01205-y · Cited by 20

Tumor necrosis factor‐α expression aberration of M1 / M2 macrophages in adult h igh‐functioning autism spectrum disorder

Yamauchi, T., Makinodan, M., Toritsuka, M., Okumura, K., Kayashima, Y., Ishida, R., Kishimoto, N., Takahashi, M., Komori, T., Yamaguchi, Y., et al. (2021) · Autism Research · doi:10.1002/aur.2585 · Cited by 21

Systems biological assessment of altered cytokine responses to bacteria and fungi reveals impaired immune functionality in schizophrenia

Gao, Y., Fan, Y., Yang, Z., Ma, Q., Zhao, B., He, X., Gao, F., Li, Q., Wang, W., Chen, C., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01362-0 · Cited by 20

The role of ferroptosis and oxidative stress in cognitive deficits among chronic schizophrenia patients: a multicenter investigation

Peng, Z., Jia, Q., Mao, J., Jiang, S., Ma, Q., Luo, X., An, Z., Huang, A., Ma, C., & Yi, Q. (2025) · Schizophrenia · doi:10.1038/s41537-025-00555-8 · Cited by 19

Hypertension and psychosis

Sudarshan, Y., & Cheung, B. M. Y. (2022) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2021-141386 · Cited by 23

Immune-Triggered Forms of Plasticity Across Brain Regions

Hikosaka, M., Kawano, T., Wada, Y., Maeda, T., Sakurai, T., & Ohtsuki, G. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.925493 · Cited by 21

Baseline C-reactive protein levels are predictive of treatment response to a neuroimmune modulator in individuals with an alcohol use disorder: a preliminary study

Grodin, E. N., Meredith, L. R., Burnette, E. M., Miotto, K. A., Irwin, M. R., & Ray, L. A. (2022) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2022.2124918 · Cited by 20

The Translational Future of Stress Neurobiology and Psychosis Vulnerability: A Review of the Evidence

Cullen, A. E., Labad, J., Oliver, D., Al‐Diwani, A., Minichino, A., & Fusar‐Poli, P. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230322145049 · Cited by 25

Microbes and Mental Illness: Past, Present, and Future

Bransfield, R. C., Mao, C., & Greenberg, R. (2023) · Healthcare · doi:10.3390/healthcare12010083 · Cited by 23

Elevated serum kynurenic acid in individuals with first-episode psychosis and insufficient response to antipsychotics

Hatzimanolis, A., Foteli, S., Xenaki, L., Selaković, M., Dimitrakopoulos, S., Vlachos, I. I., Kosteletos, I., Soldatos, R. F., Gazouli, M., Chatzipanagiotou, S., et al. (2024) · Schizophrenia · doi:10.1038/s41537-024-00483-z · Cited by 22

Bergamot Polyphenolic Fraction Supplementation Improves Cognitive Functioning in Schizophrenia

Bruno, A., Pandolfo, G., Crucitti, M., Cedro, C., Zoccali, R. A., & Muscatello, M. R. A. (2017) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000730 · Cited by 19

Specific features of immunological reactions in elderly and young patients with exacerbation of schizophrenia

Klyushnik, T. P., An, B., Sheshenin, V., Андросова, Л. В., Zozulya, S. A., Otman, I. N., & Витальевна, П. В. (2021) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202112102153 · Cited by 19

The Neutrophil‐Lymphocyte Ratio Is Positively Correlated with Aggression in Schizophrenia

Tong, Z., Zhu, J., Wang, J., Yang, Y.-J., & Hu, W. (2022) · BioMed Research International · doi:10.1155/2022/4040974 · Cited by 19

Mid-pregnancy poly(I:C) viral mimic disrupts placental ABC transporter expression and leads to long-term offspring motor and cognitive dysfunction

Monteiro, V. R. D. S., de Andrade, C. B. V., Gomes, H. R., Reginatto, M. W., Império, G. E., Fontes, K. N., Spiess, D. A., Rangel-Junior, W. S., Nascimento, V. M. D. O., Lima, C. O. S., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-14248-0 · Cited by 21

TSPO Expression and Brain Structure in the Psychosis Spectrum

Hafizi, S., Guma, E., Koppel, A., Silva, T. D., Kiang, M., Houle, S., Wilson, A., Rusjan, P., Chakravarty, M., & Mizrahi, R. (2018) · Brain, behavior, and immunity · doi:10.1016/j.bbi.2018.06.009 · Cited by 19

Schizophrenia is associated with altered DNA methylation variance

Kiltschewskij, D. J., Reay, W. R., & Cairns, M. J. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02749-5 · Cited by 19

The Dysregulation of the Glymphatic System in Patients with Psychosis Spectrum Disorders Minimally Exposed to Antipsychotics: La dérégulation du système glymphatique en présence de troubles psychotiques chez des patients peu exposés à des antipsychotiques

Korann, V., Panganiban, K. J., Stogios, N., Remington, G., Graff‐Guerrero, A., Chintoh, A. F., Hahn, M., & Agarwal, S. M. (2024) · The Canadian Journal of Psychiatry · doi:10.1177/07067437241290193 · Cited by 17

The P2X7 receptor in mood disorders: Emerging target in immunopsychiatry, from bench to bedside

von Mücke-Heim, I.-A., & Deussing, J. M. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109366 · Cited by 19

Identifying novel proteins underlying schizophrenia via integrating pQTLs of the plasma, CSF, and brain with GWAS summary data

Gu, X., Dou, M., Su, W., Jiang, Z., Duan, Q., Cao, B., & Chen, Y. (2022) · BMC Medicine · doi:10.1186/s12916-022-02679-5 · Cited by 18

Serum complement proteins rather than inflammatory factors is effective in predicting psychosis in individuals at clinical high risk

Zhang, T., Zeng, J., Ye, J., Gao, Y., Hu, Y., Xu, L., Wei, Y., Tang, X., Liu, H., Chen, T., et al. (2023) · Translational Psychiatry · doi:10.1038/s41398-022-02305-1 · Cited by 18

Association of Complement and Coagulation Pathway Proteins With Treatment Response in First-Episode Psychosis: A Longitudinal Analysis of the OPTiMiSE Clinical Trial

Susai, S. R., Föcking, M., Mongan, D., Heurich, M., Coutts, F., Egerton, A., Whetton, T., Rossum, I. W.-V., Unwin, R. D., Pollak, T. A., et al. (2023) · Schizophrenia Bulletin · doi:10.1093/schbul/sbac201 · Cited by 19

Proteome-wide Mendelian randomization reveals the causal effects of immune-related plasma proteins on psychiatric disorders

Dang, X., Song, M., Lv, L., Yang, Y., & Luo, X. (2023) · Human Genetics · doi:10.1007/s00439-023-02562-0 · Cited by 18

The human lncRNA GOMAFU suppresses neuronal interferon response pathways affected in neuropsychiatric diseases

Teng, P., Li, Y., Ku, L., Wang, F., Goldsmith, D. R., Wen, Z., Yao, B., & Feng, Y. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.06.009 · Cited by 18

Genetic proxies for antihypertensive drugs and mental disorders: Mendelian randomization study in European and East Asian populations

Fan, B., & Zhao, J. V. (2024) · BMC Medicine · doi:10.1186/s12916-023-03218-6 · Cited by 20

More dampened monocytic Toll-like receptor 4 response to lipopolysaccharide and its association with cognitive function in Chinese Han first-episode patients with schizophrenia

Chen, S., Tian, L., Chen, N., Xiu, M., Wang, Z., Wang, Y.-C., Tan, Y., & Wang, C. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.11.001 · Cited by 18

Venous Thromboembolism as an Adverse Effect During Treatment With Olanzapine: A Case Series

Masopust, J., Bazantova, V., Kuča, K., Klímová, B., & Vališ, M. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00330 · Cited by 18

Increased Dietary Inflammatory Index Is Associated with Schizophrenia: Results of a Case–Control Study from Bahrain

Jahrami, H., Faris, M. E., Ghazzawi, H., Saif, Z., Habib, L., Shivappa, N., & Hébert, J. R. (2019) · Nutrients · doi:10.3390/nu11081867 · Cited by 19

Methyl-CpG-binding protein 2 mediates overlapping mechanisms across brain disorders

Bach, S., Ryan, N., Guasoni, P., Corvin, A. P., El-Nemr, R. A., Khan, D., Sanfeliu, A., & Tropea, D. (2020) · Scientific Reports · doi:10.1038/s41598-020-79268-0 · Cited by 20

Serum IL-18 level, clinical symptoms and IL-18-607A/C polymorphism among chronic patients with schizophrenia in a Chinese Han population

Zhang, X. Y., Tan, Y., Chen, D., Tan, S., Malouta, M. Z., Bernard, J. D., Combs, J. L., Bhatti, S., Davis, M. C., Kosten, T. R., et al. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.03.002 · Cited by 18

The expression of immune related genes and potential regulatory mechanisms in schizophrenia

Yu, S., Qu, Y., Du, Z., Ou, M., Lu, R., Yuan, J., Jiang, Y., & Zhu, H. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2023.11.007 · Cited by 17

Socioenvironmental Adversity and Adolescent Psychotic Experiences: Exploring Potential Mechanisms in a UK Longitudinal Cohort

Newbury, J. B., Arseneault, L., Moffitt, T. E., Odgers, C. L., Howe, L. D., Bakolis, I., Reuben, A., Danese, A., Sugden, K., Williams, B. S., et al. (2023) · Schizophrenia Bulletin · doi:10.1093/schbul/sbad017 · Cited by 20

Study protocol for a randomized controlled trial with rituximab for psychotic disorder in adults (RCT-Rits)

Bejerot, S., Eklund, D., Hesser, H., Hietala, M. A., Kariis, T., Lange, N., Lebedev, A. V., Montgomery, S., Nordenskjöld, A., Petrović, P., et al. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-05250-5 · Cited by 17

Neuroinflammation and kynurenines in schizophrenia: Impact on cognition depending on cognitive functioning and modulatory properties in relation to cognitive remediation and aerobic exercise

Sapienza, J., Agostoni, G., Comai, S., Nasini, S., Dall’Acqua, S., Sut, S., Spangaro, M., Martini, F., Bechi, M., Buonocore, M., et al. (2024) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2024.100328 · Cited by 23

α-linolenic acid mitigates microglia-mediated neuroinflammation of schizophrenia in mice by suppressing the NF-κB/NLRP3 pathway via binding GPR120-β-arrestin 2

Wang, T., Liu, S., Shen, W., Li, J., Liu, Y., Li, Y., Zhang, F., Li, T., Zhang, X., Tian, W., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113047 · Cited by 17

Identification of Immune-Related Biomarkers of Schizophrenia in the Central Nervous System Using Bioinformatic Methods and Machine Learning Algorithms

Weng, J., Zhu, X., Ouyang, Y., Liu, Y., Lu, H., Yao, J., & Pan, B. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04461-5 · Cited by 17

Lack of CAR impacts neuronal function and cerebrovascular integrity in vivo

Boussadia, B., Gangarossa, G., Mselli-Lakhal, L., Rousset, M.-C., de Bock, F., Lassere, F., Ghosh, C., Pascussi, J., Janigro, D., & Marchi, N. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.05.018 · Cited by 17

Interleukin-3, symptoms and cognitive deficits in first-episode drug-naïve and chronic medicated schizophrenia

Xiu, M., Wang, D., Chen, S., Du, X.-D., Chen, D.-C., Chen, N., Wang, Y.-C., Yin, G., Zhang, Y., Tan, Y.-L., et al. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.02.054 · Cited by 16

Leukocyte and Brain DDR1 Hypermethylation is Altered in Psychosis and is Correlated with Stress and Inflammatory Markers

Garcia‐Ruiz, B., Moreno, L., Muntané, G., Sánchez‐Gistau, V., Gutiérrez‐Zotes, A., Martorell, L., Labad, J., & Vilella, E. (2020) · Epigenomics · doi:10.2217/epi-2019-0191 · Cited by 17

The Microbiome and Mental Health Across the Lifespan

Dickerson, F., Dilmore, A. H., Godoy‐Vitorino, F., Nguyen, T. T., Paulus, M. P., Pinto‐Tomás, A. A., Moya-Roman, C., Zúñiga-Chaves, I., Severance, E. G., & Jeste, D. V. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_384 · Cited by 17

Clinical and autoimmune features of a patient with autism spectrum disorder seropositive for anti—NMDA-receptor autoantibody

Gréa, H., Scheid, I., Gaman, A., Rogemond, V., Gillet, S., Honnorat, J., Bolognani, F., Czech, C., Bouquet, C., Toledano, E., et al. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.1/mleboyer · Cited by 16

Is it possible to stage schizophrenia? A systematic review

Martínez-Cao, C., de la Fuente-Tomás, L., García-Fernández, A., González-Blanco, L., Sáiz, P. A., García‐Portilla, M. P., & Bobes, J. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01889-y · Cited by 19

A Cross-Sectional Study on Associations Between BDNF, CRP, IL-6 and Clinical Symptoms, Cognitive and Personal Performance in Patients With Paranoid Schizophrenia

Chumakov, E. M., Dorofeikova, M., Александровна, Ц. К., & Petrova, N. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.943869 · Cited by 16

Identification of immune-related biomarkers in peripheral blood of schizophrenia using bioinformatic methods and machine learning algorithms

Zhu, X., Wang, C., Yu, J., Weng, J., Han, B., Liu, Y., Tang, X., & Pan, B. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1256184 · Cited by 18

Association of symptom severity and cerebrospinal fluid alterations in recent onset psychosis in schizophrenia-spectrum disorders – An individual patient data meta-analysis

Campana, M., Yakimov, V., Moussiopoulou, J., Maurus, I., Löhrs, L., Raabe, F. J., Jäger, I. M., Mortazavi, M., Benros, M. E., Jeppesen, R., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.04.011 · Cited by 14

What Is the Neurobiology of Schizophrenia?

Cummings, M. A., Arias, A.-L. W., & Stahl, S. M. (2024) · Cambridge University Press eBooks · doi:10.1017/9781009587747.003 · Cited by 16

What is the relationship between exposure to environmental pollutants and severe mental disorders? A systematic review on shared biological pathways

Catapano, P., Luciano, M., Cipolla, S., D'Amico, D., Cirino, A., Corte, M. C. D., Sampogna, G., & Fiorillo, A. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100922 · Cited by 16

The Role of Neuroglia in the Development and Progression of Schizophrenia

Rawani, N. S., Chan, A. W., Todd, K. G., Baker, G. B., & Dursun, S. M. (2024) · Biomolecules · doi:10.3390/biom15010010 · Cited by 19

Neurobiology of Aggressive Behavior—Role of Autoantibodies Reactive With Stress-Related Peptide Hormones

Værøy, H., Schneider, F., & Fetissov, S. O. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00872 · Cited by 16

Igg‐Dependent Hydrolysis of Myelin Basic Protein of Patients with Different Courses of Schizophrenia

Parshukova, D. A., Smirnova, L. P., Kornetova, E. G., Semke, A. V., Buneva, V. N., & Ivanova, S. А. (2020) · Journal of Immunology Research · doi:10.1155/2020/8986521 · Cited by 16

Natural Catalytic IgGs Hydrolyzing Histones in Schizophrenia: Are They the Link between Humoral Immunity and Inflammation?

Ermakov, E. A., Parshukova, D. A., Nevinsky, G. A., & Buneva, V. N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197238 · Cited by 16

Stem cell-based models and therapies: a key approach into schizophrenia treatment

Larijani, B. A., Roudsari, P. P., Hadavandkhani, M., Alavi-Moghadam, S., Rezaei–Tavirani, M., Goodarzi, P., Sayahpour, F. A., Mohamadi-Jahani, F., & Arjmand, B. (2021) · Cell and Tissue Banking · doi:10.1007/s10561-020-09888-3 · Cited by 16

Associations of Genetic Polymorphisms and Neuroimmune Markers With Some Parameters of Frontal Lobe Dysfunction in Schizophrenia

Morozova, A. Y., Zorkina, Y., Павлов, К. А., Pavlova, O., Abramova, O. V., Ushakova, V. M., Mudrak, A. V., Zozulya, S. A., Otman, I. N., Sarmanova, Z. V., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.655178 · Cited by 16

Microglia-triggered hypoexcitability plasticity of pyramidal neurons in the rat medial prefrontal cortex

Yamawaki, Y., Wada, Y., Matsui, S., & Ohtsuki, G. (2022) · Current Research in Neurobiology · doi:10.1016/j.crneur.2022.100028 · Cited by 16

The HLA 8.1 ancestral haplotype in schizophrenia: dual implication in neuro‐synaptic pruning and autoimmunity?

Tamouza, R., Krishnamoorthy, R., Giegling, I., Leboyer, M., & Rujescu, D. (2019) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13125 · Cited by 16

Microglial Activation and the Onset of Psychosis

Cannon, T. D. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15111377 · Cited by 16

Temporal changes in brain morphology related to inflammation and schizophrenia: an omnigenic Mendelian randomization study

Liu, Y., Ren, H., Zhang, Y., Deng, W., Ma, X., Zhao, L., Li, X., Sham, P., Wang, Q., & Li, T. (2024) · Psychological Medicine · doi:10.1017/s003329172400014x · Cited by 15

Clinical Perspectives on Targeting Therapies for Personalized Medicine

Singer, D. R. J., & Zaïr, Z. M. (2015) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2015.11.003 · Cited by 15

Early Inflammation Dysregulates Neuronal Circuit Formation In Vivo via Upregulation of IL-1β

Solek, C. M., Farooqi, N., Brake, N., Kesner, P., Schohl, A., Antel, J. P., & Ruthazer, E. S. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.2159-20.2021 · Cited by 16

Reduced Cell-Free Mitochondrial DNA Levels Were Induced by Antipsychotics Treatment in First-Episode Patients With Schizophrenia

Ouyang, H., Huang, M., Xu, Y., Yao, Q., Wu, X., & Zhou, D. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.652314 · Cited by 15

A randomized controlled trial of add-on naproxen, simvastatin and their combination for the treatment of schizophrenia or schizoaffective disorder

Weiser, M., Levi, L. W., Park, J., Nastas, I., Matei, V. P., Davidson, M. H., Arad, I., Dudkiewicz, I., & Davis, J. M. (2023) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2023.04.007 · Cited by 15

Recent Updates on Predicting Conversion in Youth at Clinical High Risk for Psychosis

Caballero, N., Machiraju, S. N., Diomino, A., Kennedy, L., Kadivar, A., & Cadenhead, K. S. (2023) · Current Psychiatry Reports · doi:10.1007/s11920-023-01456-2 · Cited by 17

Complete blood count-based inflammation indexes and symptom severity in people with schizophrenia spectrum disorders: An analysis based on structural equation modelling

Cavaleri, D., De Pietra, A., Gazzola, M., Crocamo, C., Bartoli, F., & Carrà, G. (2024) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2024.107134 · Cited by 15

An intricate relationship between circadian rhythm dysfunction and psychiatric diseases

Samanta, S., & Bagchi, D. (2024) · Exploration of neuroscience · doi:10.37349/en.2024.00053 · Cited by 16

Psychedelics and schizophrenia: a double-edged sword

Sapienza, J., Martini, F., Comai, S., Cavallaro, R., Spangaro, M., Gregorio, D. D., & Bosia, M. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02743-x · Cited by 20

G9a an Epigenetic Therapeutic Strategy for Neurodegenerative Conditions: From Target Discovery to Clinical Trials

Bellver‐Sanchís, A., Ribalta‐Vilella, M., Irisarri, A., Gehlot, P., Choudhary, B. S., Jana, A., Vyas, V. K., Banerjee, D. R., Pallàs, M., Guerrero, A., et al. (2025) · Medicinal Research Reviews · doi:10.1002/med.22096 · Cited by 14

Increased peripheral levels of TARC/CCL17 in first episode psychosis patients

Malmqvist, A., Schwieler, L., Orhan, F., Fatouros‐Bergman, H., Bauer, M., Flyckt, L., Červenka, S., Engberg, G., Piehl, F., & Erhardt, S. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2018.12.033 · Cited by 15

Effect of single dose N-acetylcysteine administration on resting state functional connectivity in schizophrenia

McQueen, G., Lay, A., Lally, J., Gabay, A. S., Collier, T., Lythgoe, D. J., Barker, G. J., Stone, J. M., McGuire, P. K., MacCabe, J. H., et al. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05382-1 · Cited by 15

A Cross-Species Systems Genetics Analysis Links APBB1IP as a Candidate for Schizophrenia and Prepulse Inhibition

Ashbrook, D. G., Cahill, S., & Hager, R. (2019) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2019.00266 · Cited by 16

Accumulation rate of advanced glycation end products in recent onset psychosis: A longitudinal study

Hagen, J. M., Sutterland, A. L., Edrisy, S., Tan, H. L., & de Haan, L. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113192 · Cited by 15

The role of gut-immune-brain signaling in substance use disorders

Lucerne, K. E., & Kiraly, D. D. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.09.005 · Cited by 17

Is psychosis a syndemic manifestation of historical and contemporary adversity? Findings from UK Biobank

Bhui, K. S., Halvorsrud, K., Mooney, R., & Hosang, G. M. (2021) · The British Journal of Psychiatry · doi:10.1192/bjp.2021.142 · Cited by 15

Mitochondrial Damage of Lymphocytes in Patients with Acute Relapse of Schizophrenia: A Correlational Study with Efficacy and Clinical Symptoms

Hu, A., Li, F., Guo, L., Zhao, X., & Xiang, X. (2022) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s380353 · Cited by 15

Overexpression of transmembrane TNFα in brain endothelial cells induces schizophrenia-relevant behaviors

Yeo, I. J., Yun, J., Son, D. J., Han, S., Webster, M. J., Hong, J. T., & Kim, S. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01846-7 · Cited by 15

Hypothesis: High salt intake as an inflammation amplifier might be involved in the pathogenesis of neuropsychiatric disorders

Abdoli, A. (2017) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12389 · Cited by 16

Stress dynamically regulates co-expression networks of glucocorticoid receptor-dependent MDD and SCZ risk genes

Zimmermann, C. A., Arloth, J., Santarelli, S., Loeschner, A., Weber, P. C., Schmidt, M. V., Spengler, D., & Binder, E. B. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0373-1 · Cited by 15

Association of chronic and acute inflammation of the mucosa-associated lymphoid tissue with psychiatric disorders and suicidal behavior

Isung, J., Isomura, K., Almqvist, C., Lichtenstein, P., Larsson, H., Wester, T., Rück, C., de la Cruz, L. F., Sidorchuk, A., & Mataix‐Cols, D. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0568-5 · Cited by 15

Paliperidone Reversion of Maternal Immune Activation-Induced Changes on Brain Serotonin and Kynurenine Pathways

MacDowell, K. S., Munarriz‐Cuezva, E., Meana, J. J., Leza, J. C., & Ortega, J. E. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.682602 · Cited by 19

Elevated levels of peripheral and central nervous system immune markers reflect innate immune dysregulation in autism spectrum disorder

Szabó, A., O’Connell, K. S., Akkouh, I. A., Ueland, T., Sønderby, I. E., Hope, S., Røe, A. B., Dønnum, M. S., Sjaastad, I., Steen, N. E., et al. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.116245 · Cited by 18

Implications of immunity and inflammation in schizophrenia and related psychotic disorders

Perestrelo, J., Mota, D. C. M., Coutinho, A., Santos, M. A. B. D., & Lapa, G. (2016) · European Psychiatry · doi:10.1016/j.eurpsy.2016.01.2163

Imunne system and schyzophrenia

Almeida, A., Teixeira, T. M., & Quarenta, J. (2022) · European Psychiatry · doi:10.1192/j.eurpsy.2022.1806

Imunologia da esquizofrenia: evidências, perspectivas e desafios

de Campos-Carli, S. M., Salgado, J. V., & Teixeira, A. L. (2016) · Debates em Psiquiatria · doi:10.25118/2763-9037.2016.v6.136

Is there a role for immune-to-brain communication in schizophrenia?

Khandaker, G. M., & Dantzer, R. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3975-1 · Cited by 170

The Role of Inflammation in the Etiology and Treatment of Schizophrenia

Köhler-Forsberg, O., & Lennox, B. (2020) · Frontiers research topics · doi:10.3389/978-2-88966-269-2 · Cited by 2